scholarly journals FRAGMENT-BASED DRUG DESIGN TO INHIBIT DNA METHYLTRANSFERASE 1 (DNMT1) FOR BREAST CANCER THERAPY

2019 ◽  
Vol 17 (62) ◽  
Author(s):  
Ade Hanna Natalia
2005 ◽  
Vol 280 (18) ◽  
pp. 18302-18310 ◽  
Author(s):  
Agoston T. Agoston ◽  
Pedram Argani ◽  
Srinivasan Yegnasubramanian ◽  
Angelo M. De Marzo ◽  
Mohammad Ali Ansari-Lari ◽  
...  

2021 ◽  
Vol 22 ◽  
Author(s):  
Pooja Yadav ◽  
Shreetama Bandyopadhayaya ◽  
Bridget M Ford ◽  
Chandi Mandal

Cancer is a genetic disease resulting from genomic changes, however epigenetic alterations act synergistically with these changes during tumorigenesis and cancer progression. Epigenetic variations are gaining more attraction as an important regulator in tumor progression, metastasis and therapy resistance. Aberrant DNA methylation at CpG islands is a central event in epigenetic-mediated gene silencing of various tumor suppressor genes. DNA methyltransferase 1 (DNMT1) predominately methylates at CpG islands on hemimethylated DNA substrates in proliferating cells. DNMT1 has been shown to be overexpressed in various cancer types and exhibits tumor-promoting potential. The major drawbacks to DNMT1-targeted cancer therapy are the adverse effects arising from nucleoside and non-nucleoside based DNMT1 inhibitors. This paper focuses on the regulation of DNMT1 by various microRNAs (miRNAs), which may be assigned as future DNMT1 modulators, and highlights how DNMT1 regulates various miRNAs involved in tumor suppression. Importantly, the role of reciprocal inhibition between DNMT1 and certain miRNAs in tumorigenic potential is approached with this review. Hence, this review seeks to project an efficient and strategic approach using certain miRNAs in conjunction with conventional DNMT1 inhibitors as a novel cancer therapy. It has also pinpointed to select miRNA candidates associated with DNMT1 regulation that may not only serve as potential biomarkers for cancer diagnosis and prognosis, but may also predict the existence of aberrant methylation activity in cancer cells.


2007 ◽  
Vol 85 (10) ◽  
pp. 1137-1148 ◽  
Author(s):  
Yeonjoo Jung ◽  
Jinah Park ◽  
Tai Young Kim ◽  
Jung-Hyun Park ◽  
Hyun-Soon Jong ◽  
...  

Author(s):  
Ina Nur Istiqomah ◽  
Ahmad Husein Alkaff ◽  
Mutiara Saragih ◽  
Ade Hanna Natalia ◽  
Usman Sumo Friend Tambunan

2005 ◽  
Vol 280 (31) ◽  
pp. 28828
Author(s):  
Agoston T. Agoston ◽  
Pedram Argani ◽  
Srinivasan Yegnasubramanian ◽  
Angelo M. De Marzo ◽  
Mohammad Ali Ansari-Lari ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document